Physician
Radiation Oncology
Dr. Dhara M. Macdermed, MD
|
|
Give Review
Doctor Dhara M. Macdermed, MD practices Radiation Oncology. She researched medicine at Stanford University School of Medicine. Stanford University School of Medicine is a top medical college. Stanford University School of Medicine has a rank of 2 in research and a 25 in primary care Doctor Dhara M. Macdermed, MD is a published doctor. She published 16 publications, including: 'Diverse perspectives on the current state of genomic medicine: has the revolution begun?' Dhara Macdermed accepts Medicare payments and is registered with Medicare.gov.
Publications
- Diverse perspectives on the current state of genomic medicine: has the revolution begun?
- Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy.
- MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung Cancer.
- A rationale for the targeted treatment of oligometastases with radiotherapy.
- STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect.
- Concurrent hormone and radiation therapy in patients with breast Cancer: what is the rationale?
- Extranodal nonorbital indolent lymphomas of the head and neck: relationship between tumor control and radiotherapy.
- MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients.
- Outcomes in black patients with early breast Cancer treated with breast conservation therapy.
- Symptomatic solitary skull bone metastasis as the initial presentation of a testicular germ cell tumor.
- Cannon ball lucencies from last century: lucite balls used to treat pulmonary tuberculosis.
- Tomorrow''s targeted therapies in breast Cancer patients: what is the risk for increased radiation-induced cardiac toxicity?
- Internal mammary lymph node irradiation contributes to heart dose in breast Cancer.
- Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast Cancer.
- Mitochondrial dysfunction after aerobic exposure to the hypoxic cytotoxin tirapazamine.
Schools
Stanford University
Conditions Treated
- Pituitary Gland Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Education
-
University of Chicago -
UCSF - Fresno -
Stanford University School of Medicine
Drug Facts
| NPI NUMBER | 1366616807 | |
| NPPES Provider LastName | MACDERMED | |
| NPPES Provider FirstName | DHARA | |
| NPPES Provider ZIPCode | 977016015 | |
| NPPES Provider State | OR | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 121.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 17.0 | |
| Percent Opioid Claims | 14.05 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1366616807 |
| Last Name Of The Provider | MACDERMED |
| First Name Of The Provider | DHARA |
| View All |
Similar Doctors
|
|
Dr. Russ T. Omizo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linyee J. Chang, MD
This Doctor is OpenDoctor Recommended.
|